Taiwan-developed Chinese medicine for COVID-19 nearing approval
The medicine, known as NRICM 101, was developed last year by the MOHW's National Research Institute of Chinese Medicine and a team of clinical practitioners using a mixture of 10 traditional ingredients.
2021-05-19